← Back to Search

Standardized intervention for Diabetes

N/A

Waitlist Available

Led By Julie A Schmittdiel

Research Sponsored by Kaiser Permanente

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12 months following the date of outreach into the intervention

Awards & highlights

Study Summary

This trial will test whether sending diabetes patients with poor adherence to CVD risk factor medications encouragement letters from their health care system's mail order pharmacy services will increase their use of the mail order pharmacy.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12 months following the date of outreach into the intervention

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12 months following the date of outreach into the intervention

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months following the date of outreach into the intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Percent of Participants Using Mail Order Pharmacy (MOP) After Intervention

Trial Design

2Treatment groups

Experimental Treatment

Group I: Usual careExperimental Treatment1 Intervention

Usual care

Group II: Standardized interventionExperimental Treatment1 Intervention

Standardized intervention to encourage mail order use and provide easily accessible information on how to access the service

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Standardized intervention

2017

N/A

~63020

Usual care

2011

Completed Phase 4

~23770

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Kaiser PermanenteLead Sponsor

538 Previous Clinical Trials

24,050,776 Total Patients Enrolled

11 Trials studying Diabetes

312,323 Patients Enrolled for Diabetes

National Institutes of Health (NIH)NIH

2,697 Previous Clinical Trials

6,889,802 Total Patients Enrolled

25 Trials studying Diabetes

64,177 Patients Enrolled for Diabetes

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH

2,358 Previous Clinical Trials

4,252,229 Total Patients Enrolled

107 Trials studying Diabetes

138,663 Patients Enrolled for Diabetes

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any current openings for prospective participants in this research?

"According to clinicaltrials.gov, this particular trial is no longer recruiting participants as it was last updated on August 26th 2022 and first posted on February 1st 2017. Notwithstanding that fact, there are 1174 other medical studies actively searching for volunteers at the moment."

Answered by AI

Recent research and studies

Journal of General Internal MedicineJournal

A Randomized Encouragement Trial to Increase Mail Order Pharmacy Use and Medication Adherence in Patients with Diabetes

Ramachandran, Bharathi, Connie M. Trinacty, J. Frank Wharam, O Kenrik Duru, Wendy T. Dyer, Romain S. Neugebauer, Andrew J. Karter, et al.. 2020. “A Randomized Encouragement Trial to Increase Mail Order Pharmacy Use and Medication Adherence in Patients with Diabetes”. Journal of General Internal Medicine. Springer Science and Business Media LLC. doi:10.1007/s11606-020-06237-8.

Diabetes CareJournal

Is Shelter-in-place Policy Related to Mail Order Pharmacy Use and Racial/ethnic Disparities for Patients with Diabetes?

Thomas, Tainayah W., Wendy T. Dyer, Maher Yassin, Romain Neugebauer, Andrew J. Karter, and Julie A. Schmittdiel. 2021. “Is Shelter-in-place Policy Related to Mail Order Pharmacy Use and Racial/ethnic Disparities for Patients with Diabetes?”. Diabetes Care. American Diabetes Association. doi:10.2337/dc20-2686.

Population Health MetricsJournal

Projection of the Future Diabetes Burden in the United States Through 2060

Lin, Ji, Theodore J. Thompson, Yiling J. Cheng, Xiaohui Zhuo, Ping Zhang, Edward Gregg, and Deborah B. Rolka. 2018. “Projection of the Future Diabetes Burden in the United States Through 2060”. Population Health Metrics. Springer Science and Business Media LLC. doi:10.1186/s12963-018-0166-4.

Medical CareJournal